OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy (Q2866833): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in fr: Adding French translations) |
(Changed label, description and/or aliases in de: Adding German translations) |
||
label / de | label / de | ||
OncoTarvo.: Technologische Innovation optimiert für die Personalisierung der Onkologischen Therapie |
Revision as of 09:37, 13 December 2021
Project Q2866833 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy |
Project Q2866833 in Portugal |
Statements
349,140.0 Euro
0 references
467,816.0 Euro
0 references
74.63 percent
0 references
1 March 2016
0 references
1 March 2018
0 references
HEARTGENETICS GENETICS AND BIOTECHNOLOGY, S.A.
0 references
Cantanhede
0 references
Identifiers
CENTRO-01-0247-FEDER-010500
0 references